Russo finds NJIT is the place to be for Endomedix

Four years ago, Endomedix CEO Richard Russo recognized Stony Brook University was not meeting his company’s needs when it came to facilities and experienced professors.

So he loaded up and moved down to the New Jersey Institute of Technology.

By relocating to the Newark-based university, the company has been able to tap into the institution’s human and financial resources, allowing it to keep costs at a minimum as it develops its product: a spray gel used to control bleeding during brain surgery.